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tionnaires were successfully completed (N = 538). Of
respondents, 81% had already had their implant removed
by the time of the survey. Furthermore, the vast major-
ity of these women (91%) stated that they did turn in
removal certiﬁcates to their physicians. Those who did
not have their implant removed cite a variety of reasons,
usually personal time constraints and difﬁculty identify-
ing a provider. CONCLUSION: Providers appear to be
retaining removal certiﬁcates in their ofﬁces, creating the
perception that women are not obtaining removals. This
is likely due to the known contributing factors of low
reimbursement rates and the administrative burden to
obtain reimbursement. This study emphasizes the impor-
tance of using follow-up studies in patient programs to
ascertain reasons for program underutilization and to
guide program revisions.
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OBJECTIVES: Communication of decision analytic
models is limited by their complexity and cumbersome
computation requirements, lack of end-users’ experience
and familiarity with modeling techniques, and/or access
to dedicated software applications. We explored whether
second-order Monte-Carlo simulation (MCS) and regres-
sion techniques could be used to simplify complex deci-
sion trees and facilitate their use and modiﬁcation by end
users. METHODS: This analysis was based on a previ-
ously developed 4-cycle Markov-chain model project-
ing the one-year cost utility of a continuous combined
hormone replacement therapy (CCHRT) vs. no therapy
in women with menopausal symptoms. Using the model,
we conducted 1000 MCS to project the net incremental
QALYs, costs, and net monetary beneﬁt (NMB) associ-
ated with CCHRT. Results of the MCS were summarized
using OLS regressions, in which incremental QALYs and
costs were separately predicted using the model’s inputs.
These predictors and their coefﬁcients were then used to
back-predict the NMB of CCHRT. Multiple tests were
conducted to determine the predictive abilities of the
regression. RESULTS: The net cost and QALY regressions
were associated with R2 of 0.998 and 0.880, respectively.
The model and the regression estimated the net costs asso-
ciated with CCHRT to be $400.92 and $402.53, respec-
tively. The net estimated QALY gains were 0.0380 and
0.0356, respectively. In simultaneous runs of the model
and the regression, both approaches produced concor-
dant conclusions regarding the cost-effectiveness of
CCHRT in >95% of cases (kappa >0.78; P < 0.001).
CONCLUSIONS: MCS and regression techniques can 
be combined to meaningfully and successfully simplify
complex decision trees into reduced, empirical forms.
More broadly, the regression representation may be more
universally adopted by end users, who can readily adapt
it, using basic algebra, to approximate the results of the
original decision tree to their own settings. Hopefully, 
this representation could expand appreciation of cost-
effectiveness analyses on the part of end users.
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OBJECTIVES: Hysterectomy is one of the most com-
mon surgical procedures performed, with about 600,000
surgeries a year. Studies have found that although lap-
aroscopically-assisted vaginal hysterectomies (LAVH)
offer patients shorter recovery periods, they are also 
more resource-intensive. One way to offer patients 
the improved outcome of LAVH without substantially
increasing costs, is to provide it in an outpatient setting.
This research project compares resource utilization result-
ing from the use of LAVH in outpatient versus inpatient
settings. METHODS: Patients having a laparoscopically-
assisted vaginal hysterectomy performed in Florida hos-
pitals and outpatient surgical centers during 2000 were
selected from patient-level data collected by the Florida
Agency for Health Care Administration. Patients were
excluded from the analysis if they had cancer or if they
were under 18 and over 80 years of age. For resource 
utilization analysis, multiple regression was used to com-
pare non-physician costs across both hospital inpatients
and outpatients controlling for patient characteristics.
RESULTS: In 2000, there were 3225 laparoscopically-
assisted vaginal hysterectomies performed in hospitals
and outpatient surgical centers that met our inclusion cri-
teria. Of those surgeries, most (78.4%) were performed
in a hospital. Regression results indicate that resource uti-
lization was signiﬁcantly lower for patients in the outpa-
tient setting, even after controlling for complicating
conditions such as prolapse, adhesions and leiomyomas.
Charges in the outpatient setting are about $4500 lower
than a similar procedure in the hospital. CONCLU-
SIONS: Although not all hysterectomies are appropriately
performed in the outpatient setting, it is clear that
resources can be saved by switching settings for uncom-
plicated cases. Before recommendations can be made,
further research is required to assess patients transferred
into the hospital after attempting outpatient surgery, 
and to compare patient satisfaction across the two 
settings.
